Acceleron
Acceleron is a Massachusetts-based biopharmaceutical company that develops and commercializes therapies for the treatment of pulmonary and hematologic diseases.
Business Model:
Revenue: $112.8M
Employees: 201-500
Industries / Tags:
Detailed Acceleron Information
Acceleron was acquired by
Merck Sharp &a; Dohme Sweden AB.
The acquisition happend on 2021-09-30.
Details of the transaction were not public
Acquirer
Geographic Data
Address: 128 Sidney Street
City: Cambridge
State: MA
Zip: 02139
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$493M
Raised Total:$165M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Acceleron is a Massachusetts-based biopharmaceutical company that develops and commercializes therapies for the treatment of pulmonary and hematologic diseases.
Contact Phone:
+16176499200
Contact Email:
Acceleron went public on 9/19/2013 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
9/19/2013
IPO Valuation:
$385M
Ticker Symbol:
XLRN
IPO Price:
$15/share
Amount Raised:
$84M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
